Works by Xiong, Anwen

Results: 14

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.757993

By:

Xiong, Anwen;
Wang, Jiali;
Zhou, Caicun

Publication type:

Article

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.639947

By:

Liu, Sangtian;
Wu, Fengying;
Li, Xuefei;
Zhao, Chao;
Jia, Yijun;
Jia, Keyi;
Han, Ruoshuang;
Qiao, Meng;
Li, Wei;
Yu, Jia;
Zhou, Fei;
Xiong, Anwen;
Chen, Bin;
Fan, Jue;
Ren, Shengxiang;
Zhou, Caicun

Publication type:

Article

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22801-0

By:

Wu, Fengying;
Fan, Jue;
He, Yayi;
Xiong, Anwen;
Yu, Jia;
Li, Yixin;
Zhang, Yan;
Zhao, Wencheng;
Zhou, Fei;
Li, Wei;
Zhang, Jie;
Zhang, Xiaosheng;
Qiao, Meng;
Gao, Guanghui;
Chen, Shanhao;
Chen, Xiaoxia;
Li, Xuefei;
Hou, Likun;
Wu, Chunyan;
Su, Chunxia

Publication type:

Article

Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial.

Published in:

BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02696-4

By:

Zhu, Xinsheng;
Sun, Liangdong;
Song, Nan;
He, Wenxin;
Xie, Boxiong;
Hu, Junjie;
Zhang, Jing;
Yang, Jie;
Dai, Jie;
Bian, Dongliang;
Xia, Haoran;
Sun, Fenghuan;
Xiong, Anwen;
Luo, Jie;
Zhang, Lele;
Yu, Huansha;
Liu, Ming;
Liu, Hongcheng;
Wang, Haifeng;
Zhang, Haiping

Publication type:

Article

CXCR1<sup>+</sup> neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02045-2

By:

Wang, Haowei;
Xiong, Anwen;
Chen, Xiaoxia;
Guo, Junhong;
Tang, Zhuoran;
Wu, Chunyan;
Ren, Shengxiang;
Zhou, Caicun;
Chen, Jian;
Hou, Likun;
Jiang, Tao

Publication type:

Article

First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02006-9

By:

Li, Wei;
Wang, Yongsheng;
Xiong, Anwen;
Gao, Ge;
Song, Zhengbo;
Zhang, Yiping;
Huang, Dingzhi;
Ye, Feng;
Wang, Qiming;
Li, Zhihui;
Liu, Jiaye;
Xu, Chunwei;
Sun, Yinghui;
Liu, Xijie;
Zhou, Fei;
Zhou, Caicun

Publication type:

Article

Immunoengineered magnetic-quantum dot nanobead system for the isolation and detection of circulating tumor cells.

Published in:

Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-00860-1

By:

Zhang, Pengfei;
Draz, Mohamed S.;
Xiong, Anwen;
Yan, Wannian;
Han, Huanxing;
Chen, Wansheng

Publication type:

Article

Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03715-4

By:

Ren, Shengxiang;
Xiong, Anwen;
Yu, Jia;
Wang, Xicheng;
Han, Baohui;
Pan, Yueyin;
Zhao, Jun;
Cheng, Yufeng;
Hu, Sheng;
Liu, Tianshu;
Li, Yalun;
Cheng, Ying;
Feng, Jifeng;
Yi, Shanyong;
Gu, Shanzhi;
Gao, Shegan;
Luo, Yongzhong;
Liu, Ying;
Liu, Caigang;
Duan, Huijie

Publication type:

Article

A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer.

Published in:

2018

By:

Wu, Fengying;
Zhang, Shijia;
Xiong, Anwen;
Gao, Guanghui;
Li, Wei;
Cai, Weijing;
Su, Chunxia;
Chen, Xiaoxia;
Zhou, Fei;
Zhao, Jing;
Ren, Shengxiang;
Zhou, Caicun

Publication type:

journal article

Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study.

Published in:

2017

By:

Tao Jiang;
Ruirui Cheng;
Guowei Zhan;
Chunxia Su;
Chao Zhao;
Xuefei Li;
Jie Zhang;
Fegnying Wu;
Xiaoxia Chen;
Guanghui Gao;
Wei Li;
Weijing Cai;
Fei Zhou;
Jing Zhao;
Anwen Xiong;
Shengxiang Ren;
Guojun Zhang;
Caicun Zhou;
Jun Zhang;
Jiang, Tao

Publication type:

journal article

EGFR‐TKIs plus local therapy demonstrated survival benefit than EGFR‐TKIs alone in EGFR‐mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases.

Published in:

International Journal of Cancer, 2019, v. 144, n. 10, p. 2605, doi. 10.1002/ijc.31962

By:

Jiang, Tao;
Chu, Qian;
Wang, Huijuan;
Zhou, Fei;
Gao, Guanghui;
Chen, Xiaoxia;
Li, Xuefei;
Zhao, Chao;
Xu, Qinghua;
Li, Wei;
Wu, Fengying;
Xiong, Anwen;
Zhao, Jing;
Xu, Yaping;
Su, Chunxia;
Ren, Shengxiang;
Zhou, Caicun;
Hirsch, Fred R.

Publication type:

Article

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 12777, doi. 10.2147/OTT.S286600

By:

Sun, Chenglong;
Zhou, Fei;
Li, Xuefei;
Zhao, Chao;
Li, Wei;
Li, Jiayu;
Xiong, Anwen;
Yu, Jia;
Gao, Guanghui;
Wang, Qi;
Wu, Fengying;
Zhou, Caicun

Publication type:

Article

Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221136759

By:

Zhou, Fei;
Guo, Haoyue;
Zhou, Xiaolong;
Xie, Huikang;
Tian, Tian;
Zhao, Wencheng;
Gao, Guanghui;
Xiong, Anwen;
Wang, Lei;
Li, Wei;
Chen, Xiaoxia;
Zhang, Yan;
Fan, Jue;
Wu, Fengying;
Zhang, Yongchang;
Zhou, Caicun

Publication type:

Article

Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study.

Published in:

Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01651-5

By:

Mao, Chenyu;
Xiong, Anwen;
Qian, Jiong;
Wang, Wenxiang;
Liu, Ying;
Zhang, Tao;
Wu, Zhihai;
Ni, Haiqing;
Lu, Jia;
Long, Sixiang;
Zhao, Li;
Chen, Yuling;
Zhou, Caicun;
Xu, Nong

Publication type:

Article